RSS  JOBS   SITE MAP 
 HOME 
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
 RESOURCE CENTER 
 SUBSCRIBE 
 SUBSCRIBE ASIA DIGEST 
  Friday, September 3, 2010 SEARCH     
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
MORE FEATURES
Diabetes pipeline-Clinical research in progress
Sanjeev Jain
A look at the diabetes research happening across APAC region
Next big bet for pharma companies: GCC
Narayan Kulkarni
Flush with petro dollars, most countries in the Gulf are rich. They provide free or subsidized healthcare to not only their citizens but also to the expat population. The six- country GCC is a massive spender on healthcare
MOST READ FEATURES
"ICMR provides encouraging leads for product development"
Rahul Koul
In an exclusive interview with BioSpectrum, Dr Vishwa Mohan Katoch, director general, Indian Council of Medical Research and secretary, Department of Health Research, shares his views on key operations and priorities of ICMR and a host of issues.
'In India, NICE has an interest in the National Rural Health Mission'
Nayantara Som
Dr Kalipso Chalkidou, Director, NICE International, throws light on the various initiatives taken by NICE, and a bird's eye view of the organization during a freewheeling conversation with Nayantara Som of BioSpectrum in early 2010, at London.
TODAY'S NEWS
  Scientists discover protein that fuels Alzheimer's disease
  Agensys initiates phase I of renal cancer drug
  Pfizer to acquire drug developer FoldRx
  Varian establishes radiotherapy training center in India
  Yongye enters into $59 mn revolving credit facilities
  Ono licenses Concordia's cancer drug in Japan
 
Advertisement
 
Digital Mag

Issue: July, 2010
Current Issue
View / Download
Top Story
Are biofuels poised for a leap?
 
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement



















 

FEATURES
 
2012 not the end of world for pharma: IMS Health
The new study by IMS Health predicts that the period between 2015- 2020 will see accelerated growth with pharma companies breaking away from the traditional strategy of replying to a few blockbusters
 
"ICMR provides encouraging leads for product development"
In an exclusive interview with BioSpectrum, Dr Vishwa Mohan Katoch, director general, Indian Council of Medical Research and secretary, Department of Health Research, shares his views on key operations and priorities of ICMR and a host of issues.
 
'In India, NICE has an interest in the National Rural Health Mission'
Dr Kalipso Chalkidou, Director, NICE International, throws light on the various initiatives taken by NICE, and a bird's eye view of the organization during a freewheeling conversation with Nayantara Som of BioSpectrum in early 2010, at London.
 
'In terms of functional services, India and China remain the countries of focus'
In a freewheeling interview with BioSpectrum, Dr Stephen Cutler,Senior Vice President and Chief Operating Officer, Kendle, throws light on the company's APAC strategy and the crucial role the region will have to play in their overall global strategy
 
Influenza vaccine market - What is holding Asia back?
History tells us that serious influenza pandemics, due to major shifts in the prevailing viral serotype as a new serotype crosses from birds to humans, occur on average every 30-40 years.
 
Human vaccine industry in India: Ground realities
India is one of the leading "emerging market" economies which has witnessed significant economic growth and is now poised to do even better.
 
Overcoming regional CMO capacity bottlenecks
Having defined the ideal attributes for its desired CMO partner, BPA embarked upon a global CMO engagement mission in third quarter 2009. From that process DSMB emerged as the preferred commercial operator, with binding documents executed in Dec 09.
 
The biosimilars quality imperative
The entry of biosimilars could pave the way for affordable therapies, consequently benefiting a larger patient population on a global basis.
 
Top 10 products in Asia bring in $3.3 billion
Lipitor from Pfizer leads the competitive market of Asia Pacific region with sales revenue of $800 mn in 2009. After experiencing a growth phase over the past few years, the global pharma market is passing through a stagnant phase
 
Diabetes pipeline-Clinical research in progress
A look at the diabetes research happening across APAC region
More
 
Advertisement





 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black